Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7%
Launched by HOSPITAL REGIONAL DE ALTA ESPECIALIDAD DEL BAJIO · Apr 9, 2015
Trial Information
Current as of July 07, 2025
Completed
Keywords
ClinConnect Summary
Clinical triple-blind randomized controlled trial.
With two arms to the study:
1. Mouth rinses with chlorhexidine-based solution at a concentration of 0.12%, using as a vehicle to 7% ethyl alcohol.
2. Mouthwashes with solution based only 7% ethyl alcohol.
GOAL. Assess whether there decrease in the rate of oral colonization by gram-negative bacteria in patients with chemotherapy by using chlorhexidine mouthwash.
SPECIFIC OBJECTIVES:
1. The rate of the oral colonization by gram-negative bacteria initiation of chemotherapy.
2. The rate of oral colonization by gram-negative bacteria after ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients over 18years, no upper age limit.
- • 2. Acceptance of participation in the study.
- • 3. Signature of informed consent.
- • 4. Inpatient and remain hospitalized for at least 10 days.
- 5. The following haematological diagnosis:
- • 1. acute lymphoblastic leukemia.
- • 2. acute myelogenous leukemia.
- • 3. relapsed non-Hodgkin lymphoma.
- • 6. Receiving Chemotherapy scheme as a treatment for the underlying disease
- Exclusion Criteria:
- • 1. Patients who choose not to participate in the study.
- • 2. Patients in whom no possible mouthwashes.
- • 3. Patients who willingly choose to withdraw from the study.
- • 4. Patients who develop conditions in which the administration is not possible rinses.
- • 5. Duration of hospital stay less than 10 days, regardless of cause.
About Hospital Regional De Alta Especialidad Del Bajio
Hospital Regional de Alta Especialidad del Bajío is a leading healthcare institution dedicated to providing advanced medical services and specialized care in the Bajío region of Mexico. Renowned for its commitment to high-quality patient care, the hospital also plays a pivotal role in clinical research, facilitating trials that advance medical knowledge and improve treatment outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the hospital is focused on fostering innovation and collaboration in clinical research, ensuring that patients have access to cutting-edge therapies and clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leon, Guanajuato, Mexico
Patients applied
Trial Officials
Lauro F Amador, Researcher
Principal Investigator
Hospital Regional Alta Especialidad Bajio
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials